- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05398744
Motivational Interviewing and Group Heart Transplant Exercise and Education: A Pilot Study (MIGHTEE)
MIGHTEE: Motivational Interviewing and Group Heart Transplant Exercise and Education: A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Orthotopic heart transplant (OHT) is the definitive therapy for children with cardiac disease, however, survival after transplant is limited, and quality of life after transplant is less than healthy peers'. The transplanted heart usually works well, pumping blood as well as most healthy hearts. As such, the American Heart Association recommends no specific exercise related restrictions for heart transplant recipients. Although most children have normal cardiac function after OHT, children with transplanted hearts have impaired exercise performance, and do not exercise as much as their peers. This finding is concerning, as impaired exercise tolerance is associated with reduced survival, diminished health related quality of life, and depression and anxiety. These factors negatively impact adherence, and further limit graft survival. Thus, identifying interventions that positively impact physical activity and promote graft longevity, like individualized exercise programs, should be a priority for post-transplant care.
Investigators propose that increasing physical activity in children and adolescents after OHT may be a critical modifiable method for increasing graft longevity and improving quality of life. Investigators will explore this through a pilot program. Participants will wear an activity monitor to record physical activity, parents/caregivers and participants will complete surveys, and participants will engage with psychologists and exercise physiologists.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Children's Hospital of Philadelphia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria for Patients
- Age 12-18 years old
- More than 12 months removed from their initial heart transplant
- Agreement to participate in study protocol and willing/able to return for follow-up.
- Access to computer and/or internet for uploading health data from wearable electronic activity monitor.
- Access to an electronic device (phone, tablet, or computer) with a camera feature, microphone, and the capacity to use Zoom, the virtual platform which will stream the group exercise session.
- Clinical EKG with normal sinus rhythm
- English language proficiency
Exclusion Criteria for Patients
- Patients who are restricted from exercise
- Patients who are pregnant
- History of pharmaceutically treated rejection within the prior 6 months
- Physical or behavioral conditions that would prevent them from participating in aerobic exercise (i.e., significant motor disability, illness precluding participation in the exercise regimen as described).
- Inability to complete a standard maximal exercise stress test (as defined by those who did not achieve an respiratory exchange ratio (RER)>1.1 and who gave submaximal effort according to exercise physiologist performing EST)
- EKG or ambulatory rhythm monitor performed within the last 12 months which shows 2nd or 3rd degree atrioventricular (AV) block
- Patients with a medication change after their baseline EST expected to affect their heart rate response to exercise (i.e. initiation/discontinuation of a beta-blocker, beta-agonist during exercise, or ivabradine)
- Pacemaker
Inclusion Criteria for Parents
- Parent of a patient that fits all inclusionary/exclusionary eligibility criteria
- English language proficiency at least at a 5th grade level or for limited English proficient (LEP) parents, preferred language proficiency of at least a 5th grade level
Exclusion Criteria for Parents
- Unwilling to complete questionnaires
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual group aerobic training program
16-week, virtual group aerobic training program led by exercise physiologist.
Duration: 24 weeks.
Four weeks recording of baseline activity through activity monitor; 16-week virtual group aerobic training program, 3 times per week for 30 minutes; and four weeks of follow-up.
|
At-home, aerobic group exercise program facilitated by exercise physiologist via video format, 3 times a week for 16 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Study feasibility assessed by participation in training sessions
Time Frame: 16 weeks
|
Attendance at assigned training sessions
|
16 weeks
|
Study feasibility evaluated by participants' engagement on the activity monitor application
Time Frame: 24 weeks
|
Days of logged activity on the MyHeart application
|
24 weeks
|
Study feasibility assessed by participants' engagement with exercise physiologist
Time Frame: 24 weeks
|
Participants' attendance at biweekly meetings with exercise physiologist
|
24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical activity of participants
Time Frame: 24 weeks
|
Time spent at target heart rate
|
24 weeks
|
Health Related Quality of life
Time Frame: 24 weeks
|
Health related quality of life (HRQL) will be measured by participants' responses to Pediatric Quality of Life (PEDSQL) questionnaire, generating scores from 0-100 with a higher score indicating better quality of life.
|
24 weeks
|
Psychological well-being
Time Frame: 24 weeks
|
Psychological well-being will be evaluated by participants' responses on questionnaires using Patient Reported Outcome Measurement Information System (PROMIS).
PROMIS measures generate T-scores.
T-scores are standard scores with a mean of 50 and standard deviation of 10 in a reference population (usually U.S. general population) with a higher score indicating more of the psychological concept being measured.
|
24 weeks
|
Perceived exercise barriers or exercise barriers
Time Frame: 24 weeks
|
Exercise barriers will be measured by analysis of survey responses related to physical activity practices
|
24 weeks
|
Participants' overall program satisfaction
Time Frame: 24 weeks
|
Participants' overall program satisfaction will be analyzed by review of completed post-intervention questionnaires
|
24 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jonathan Edelson, MD, Children's Hospital of Philadelphia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 21-018888
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Orthotopic Heart Transplant
-
Tomoaki KatoUnknown
-
Bryan GoldsteinCompletedOrthotopic Heart TransplantUnited States
-
Children's Healthcare of AtlantaTerminated
-
Emory UniversityTerminated
-
Boston Scientific CorporationCompletedAnastomotic Biliary Stricture Post Orthotopic Liver TransplantUnited States
-
Assiut UniversityNot yet recruitingOrthotopic NeobladdersEgypt
-
Nicasio ManciniAzienda Ospedaliera Città della Salute e della Scienza di Torino; Azienda Ospedaliero...Unknown
-
Washington University School of MedicineCompletedPatients With Post Orthotopic Heart Transplantation StatusUnited States
-
Zhujiang HospitalRecruitingOrthotopic NeobladderChina
-
University Health Network, TorontoNot yet recruitingSolid Organ Transplant | Liver Transplant | Kidney Transplant | Heart Transplant
Clinical Trials on Group Exercise Program
-
Riphah International UniversityCompletedSports Physical TherapyPakistan
-
Istanbul University - Cerrahpasa (IUC)RecruitingMultiple SclerosisTurkey
-
Chang Gung Memorial HospitalCompleted
-
Rosimeire Simprini PadulaUnknownMusculoskeletal Disorder of the NeckBrazil
-
Universidad Politecnica de MadridUnknown
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetic Foot UlcerUnited States
-
University of Colorado, DenverNot yet recruiting
-
University of ThessalyCompletedFunctionality, Falls, Elderly, Fall Prevention, Exercise Elderly, Assessment, Rehabilitation, Community-DwellingGreece
-
Istanbul Medipol University HospitalRecruiting
-
Riphah International UniversityCompletedSports Physical TherapyPakistan